These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36221063)

  • 1. Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.
    Shaaban M; Elshaer SL; Abd El-Rahman OA
    BMC Microbiol; 2022 Oct; 22(1):247. PubMed ID: 36221063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of extended-spectrum β-lactamase, AmpC, and carbapenemase production in Proteus mirabilis.
    Datta P; Gupta V; Arora S; Garg S; Chander J
    Jpn J Infect Dis; 2014; 67(1):44-6. PubMed ID: 24451101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of carbapenemases bla
    Haider MH; McHugh TD; Roulston K; Arruda LB; Sadouki Z; Riaz S
    Ann Clin Microbiol Antimicrob; 2022 May; 21(1):18. PubMed ID: 35590320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011.
    Yang JH; Sheng WH; Hsueh PR;
    J Glob Antimicrob Resist; 2020 Sep; 22():398-407. PubMed ID: 32311502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.
    Park MJ; Kim TK; Song W; Kim JS; Kim HS; Lee J
    Ann Lab Med; 2013 Sep; 33(5):353-5. PubMed ID: 24003426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing
    Habibzadeh N; Peeri Doghaheh H; Manouchehri Far M; Alimohammadi Asl H; Iranpour S; Arzanlou M
    Microb Drug Resist; 2022 Sep; 28(9):921-934. PubMed ID: 36067095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
    ElTaweel M; Said HS; Barwa R
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of β-Lactamase-Producing Proteus mirabilis Strains of Animal Origin in Andhra Pradesh, India and Their Genetic Diversity.
    Chinnam BK; Nelapati S; Tumati SR; Bobbadi S; Chaitanya Peddada V; Bodempudi B
    J Food Prot; 2021 Aug; 84(8):1374-1379. PubMed ID: 33725112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
    Khan MK; Thukral SS; Gaind R
    Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Detection and Antibiogram of β-lactamase-producing
    Pal N; Hooja S; Sharma R; Maheshwari RK
    Ann Med Health Sci Res; 2016; 6(5):267-273. PubMed ID: 28503342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of multidrug-resistant Enterobacterales carrying extended-spectrum beta-lactamase and AmpC genes isolated from neonatal sepsis in Ahvaz, Iran.
    Mansouri S; Savari M; Malakian A; Abbasi Montazeri E
    BMC Microbiol; 2024 Apr; 24(1):136. PubMed ID: 38658819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
    Sheng WH; Badal RE; Hsueh PR;
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt.
    Mohamed ES; Khairy RMM; Abdelrahim SS
    Antimicrob Resist Infect Control; 2020 Dec; 9(1):198. PubMed ID: 33303028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Urinary Catheter to the Prevalence of Three Classes of Integrons,
    Mirzaei A; Nasr Esfahani B; Raz A; Ghanadian M; Moghim S
    Biomed Res Int; 2021; 2021():9952769. PubMed ID: 34212042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals.
    Abdalhamid B; Albunayan S; Shaikh A; Elhadi N; Aljindan R
    J Med Microbiol; 2017 Sep; 66(9):1286-1290. PubMed ID: 28820112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Hodžić D; Bedenić B
    Med Glas (Zenica); 2016 Aug; 13(2):103-12. PubMed ID: 27313108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.